Of the remaining 26 patients with normal CEs P0 or without significant findings to explain the bleeding P1, 65% received medical treatment and showed no recurrence of OGB during follow-up.
De los restantes 26/60 pacientes con CE normales P0 o sin hallazgo significativo que expliquen el sangrado P1, 65% recibieron tratamiento médico y no presentaron recurrencia de SGO durante el seguimiento.